| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $323.55 | $2,329,541.38 | -23.7% | +17.0% | -6.1% | |
| Aug 5, 2024 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 333,332 | $16.51 | $5,504,610.78 | -13.1% | +16.4% | +211.2% | |
| Aug 5, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 68,976 | $0.15 | $10,434.68 | +1.9% | - | - | |
| Aug 2, 2024 | AMRN Amarin Corp Plc\uk | Berg Aaron | President And CEO | Buy | 160,000 | $0.64 | $102,400.00 | +24.8% | -9.4% | +18.4% | |
| Aug 2, 2024 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | Director | Sell | 10,481 | $95.50 | $1,000,899.61 | -0.8% | +12.6% | -27.7% | |
| Aug 2, 2024 | ETST Earth Science Tech, Inc. | Tabraue Mario Guillermo | COO | Buy | 15,000 | $0.17 | $2,550.00 | +0.1% | - | - | |
| Aug 2, 2024 | UTHR United Therapeutics Corp | Dwek Raymond | Director | Sell | 5,000 | $325.35 | $1,626,734.50 | -19.1% | +14.1% | -10.2% | |
| Aug 2, 2024 | PCRX Pacira Biosciences, Inc. | Slonin Jonathan72 | Chief Medical Officer | Sell | 945 | $20.05 | $18,947.25 | -1.0% | -21.9% | +3.8% | |
| Aug 2, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 4,000 | $0.07 | $295.00 | - | - | - | |
| Aug 2, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $324.32 | $2,335,109.22 | -15.3% | +14.1% | -10.2% | |
| Aug 1, 2024 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 12,632 | $153.26 | $1,936,016.95 | -41.0% | -18.8% | -15.8% | |
| Aug 1, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 2,054 | $22.00 | $45,188.00 | -1.1% | +2.9% | +237.9% | |
| Aug 1, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Hughes Eric A | See "remarks" | Sell | 24,537 | $17.25 | $423,280.43 | -35.3% | +6.0% | -12.3% | |
| Aug 1, 2024 | DERM Journey Medical Corp | Benesch Joseph | CFO | Sell | 9,324 | $5.47 | $51,002.28 | -16.5% | +3.5% | +26.4% | |
| Aug 1, 2024 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 2,996 | $154.01 | $461,422.95 | -7.0% | -18.8% | -15.8% | |
| Jul 31, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 10,282 | $44.23 | $454,772.86 | -9.9% | +17.5% | -51.9% | |
| Jul 31, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 3,600 | $318.39 | $1,146,209.76 | -17.8% | +12.6% | -12.3% | |
| Jul 31, 2024 | INM Inmed Pharmaceuticals Inc. | Mancini Alexandra Diane Janet | Consultant | Sell | 240 | $0.18 | $42.31 | -100% | +65.0% | -30.9% | |
| Jul 30, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $336.56 | $2,423,235.38 | -25.5% | +3.6% | -16.5% | |
| Jul 26, 2024 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 1,833 | $11.44 | $20,969.52 | -1.6% | -5.0% | +68.5% | |
| Jul 26, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $338.75 | $2,439,009.69 | -23.9% | +3.5% | -10.0% | |
| Jul 24, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 24,803 | $22.17 | $549,991.75 | -6.3% | +4.8% | +154.6% | |
| Jul 24, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $334.69 | $2,409,782.47 | -26.7% | +11.7% | -7.6% | |
| Jul 23, 2024 | DERM Journey Medical Corp | Benesch Joseph | CFO | Sell | 4,055 | $5.40 | $21,897.00 | -6.7% | +16.8% | +36.6% | |
| Jul 23, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,335 | $20.29 | $47,377.15 | -1.4% | +1.2% | +154.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.